Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Mafuma aims at elusive tournament victory with Junior Springboks
2016-06-03

Description: Mafuma Tags: Mafuma

The University of the Free State’s Mosolwa Mafuma
recently scored five tries in the Junior Springboks’
three practice matches against a Golden Lions U20
invitation team, a Maties team, and the
South Western Districts. Photo: SASPA

He has never won a rugby tournament, so Mosolwa Mafuma has only one goal: to win the Junior World Cup as Junior Springbok in England.

Even though the 20-year-old Shimlas wing has achieved success, and it is pleasing to excel individually, he believes it is more satisfying when his team triumphs. According to Mafuma, who could just as well be an athletics star, he wants to help the South African U20 team take a different approach.

He and the prop Kwenzo Blose are players from the University of the Free State who will represent the Junior Springboks from 7 to 25 June 2016 in Manchester. The team will play the first of three group matches on 7 June 2016 against Japan in the Academy Stadium.

New approach for SA U20 team
Mafuma, who was Player of the Tournament in his first Varsity Cup in 2016, says the Junior Springboks are well prepared. “We have the skills, and the structures at the Junior Springboks are different than before. There is not just one game plan like playing with big guys. We want to try new things and have a different approach.”

It is with this team that he wishes to achieve something. “It is one thing to be able to say that you are the Player of a Tournament, but your team did not win. I have not won something at school (with St. Benedict’s Boys College in Johannesburg) or this year with the Shimlas.”

Speedster on athletics track
The speedster is one of only a few rugby players who also have a profile on the IAAF website. His fastest time in the 100 m is 10.37 seconds (a national U17 record) and 20.37 s in the 200 m.

In high school, this first-year Psychology student played rugby during winter and took part in athletics during summer. Only at the end of Grade 11 did he started focusing on rugby. “I was more of an athlete than a rugby player,” he says.

It is no coincidence that the nickname he acquired due to his speed, is Dash. His other nickname, Senkie (derived from the Afrikaans word ‘seuntjie’) he received as a child from his parents because he was such a small child.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept